Redcliffe Labs

What Redcliffe Labs does

Redcliffe Labs (legally Redcliffe Lifetech Private Limited) is an India-based omnichannel diagnostics platform offering pathology and radiology services through a nationwide network of 80+ self-owned certified laboratories and 2,000+ collection centres across 220+ cities and 4,000+ pin codes, with a particular concentration in Tier 2/3/4 markets that account for over 70% of diagnostic volumes. The company runs India's widest home sample-collection network through trained phlebotomists and an omnichannel booking stack spanning website, mobile app, phone, and WhatsApp, while processing 70,000+ tests daily across a 3,600+ test menu that includes routine pathology and genetic testing. Technology investments include AI-powered smart reports with colour-coded insights and simplified summaries, drone-based sample transport (including India's first commercial medical drone corridor between Uttarkashi and Dehradun), AI-powered facial scan for instant wellness screening, temperature-controlled logistics with real-time monitoring, and QR-coded report verification.

The business model is a hybrid of transactional test fees, health package sales, and subscription/membership programmes (VIP, VIP Gold, One Health Plan), supplemented by gift cards and corporate-wellness contracts. Brand portfolio extends beyond core pathology to Femcliffe (women's health), GeneCliffe and its genetic sub-brands (CardioCliffe, OncoCliffe, NeuroCliffe, ReproCliffe, NephroCliffe, GutMicrobiome, Health EX), and the recently launched Annual Health Report Card for longitudinal tracking. Acquisitions of Medicentre Sonography & Clinical Lab (Southern Rajasthan, 2023), Celara Diagnostics (Bengaluru, 2024) and a high-end imaging centre in Ajmer (2026) underpin an inorganic roll-up into integrated radiology + pathology ecosystems across India.

The customer base of 1 crore+ (10M+) is long-tailed, dominated by individual consumers using both transactional preventive packages (₹997-₹1,799 typical full-body bundles, advertised at 64-79% off MRP) and subscription programmes, with secondary segments in corporate wellness and healthcare-provider referrals. Redcliffe has raised approximately $103M cumulatively across multiple rounds including a $61M Series B (May 2022, LeapFrog-led) and a $42M Series C (September 2024, IFU-led). FY25 revenue stood at ₹419 crore (up 20% YoY), with EBITDA losses reduced from -38% to -21% and a stated path to EBITDA-positive by H2 FY26 alongside a FY26 revenue target of ₹560 crore. Divestiture of Crysta IVF to Moon Care (2026) sharpens focus on core diagnostics, while new C-suite hires including a dedicated Chief Business Officer for Inorganic Growth formalise continued M&A-led expansion and a potential future IPO.

Name

Redcliffe Labs

Legal name

Redcliffe Lifetech Private Limited

Website

https://redcliffelabs.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Redcliffe Labs is an India-based omnichannel diagnostics platform offering pathology and radiology services through 80+ self-owned labs, 2,000+ collection centres, and India's widest home sample-collection network across 220+ cities, serving over 1 crore individual consumers primarily in Tier 2-4 markets.

Ownership category

akta.pro rank

Product category

Diagnostic Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYHLAFAMAJ

Reference & Esoteric Testing Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAFAMAH

Genetic & Prenatal Testing Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHSABACAN

Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home)

Home & Personal Services/Elder Care & In-Home Care Services/Skilled Nursing & Clinical Home Health

SECONDARYHLALAAAE

At-Home Lab Testing & Diagnostics-Integrated Virtual Care

Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

SECONDARYHLAAAMAC

Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)

Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

SECONDARYHLAHACAL

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

• Diagnostic testing services
• Pathology laboratory services
• Home sample collection
• Preventive health checkups
• Radiology and imaging

Headquarters

HQ city

Noida

HQ country

India

HQ region

Asia

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Diagnostic Testing Services: Pathology and genetic testing services offered through 3,600+ tests across 80+ labs. Revenue from individual test bookings and health packages.
2. Health Packages: Curated diagnostic health packages including full body checkups, organ-specific tests, and preventive screening packages
3. VIP Membership Programs: VIP membership offering 10% discount across pathology tests, free sample collection for premium slots, RedCash loyalty rewards
4. One Health Subscription: Annual subscription plan with 15 free tests up to Rs 1,500 per order plus initial full body health checkup
5. Gift Cards: Gift cards sold for diagnostic services on website and mobile app, valid for 12 months from issuance

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels9 records

Core offering

Redcliffe Labs operates an omnichannel diagnostics platform offering pathology and radiology services, with 3,600+ tests available across 80+ self-owned certified laboratories and a home sample collection network spanning 220+ Indian cities. Customers can book individual tests, doctor-curated health packages, genetic tests (GeneCliffe) and women's health packages (Femcliffe) online or via phone/WhatsApp, with phlebotomists collecting samples at home in temperature-controlled bags and reports delivered digitally with AI-generated summaries.

Differentiator

Problem solved

Functional benefit

Brands

• GeneCliffe: Genetic testing platform offering DNA, chromosome and protein analysis for personalized health insights including CardioCliffe, NephroCliffe, Health EX, GutMicrobiome, ReproCliffe, OncoCliffe, and NeuroCliffe
• Femcliffe
• CardioCliffe
• NephroCliffe
• OncoCliffe
• NeuroCliffe
• ReproCliffe
• GutMicrobiome
• Health EX

Products and services

• Pathology and Diagnostic Testing Services Core pathology, haematology, biochemistry, microbiology and genetic testing services delivered through self-owned labs across 220+ Indian cities for individual consumers, referring doctors and corporate customers.
• Doctor-Curated Health Checkup Packages Curated multi-parameter preventive health packages such as Fit India Full Body Checkup - Essential (94 parameters), Smart Full Body Checkup (89 parameters) and Annual Full Body Checkup - Advance (96 parameters), targeting individual consumers and families for routine and preventive screening.
• Home Sample Collection Service Trained phlebotomist-led home visit sample collection across 220+ cities and 4,000+ pin codes using temperature-controlled bags and real-time temperature monitoring, available via website, mobile app, phone and WhatsApp booking.
• GeneCliffe Genetic Testing Platform Genetic testing umbrella offering DNA, chromosome and protein-based personalised health insights through specialised products including CardioCliffe, NephroCliffe, NeuroCliffe, OncoCliffe, ReproCliffe, GutMicrobiome and Health EX.
• Femcliffe Women's Health Diagnostic Platform India's first she-centric diagnostic platform offering women-specific health packages, cervical cancer screening (HPV and pap smear tests), and reproductive health diagnostics targeted at female consumers.
• Redcliffe Medicentre Imaging & Labs (Radiology Services) Radiology and advanced imaging services offered through the acquired Medicentre Imaging & Labs facility in Ajmer, complementing Redcliffe's pathology offerings across India.
• AI-Powered Face Scan Wellness Screening AI computer-vision based facial scan offering instant wellness screening and health risk assessment for consumers, deployed as a top-of-funnel screening tool in campaigns.
• Annual Health Report Card India's first annual health report card providing a consolidated longitudinal view of an individual's health parameters, vitals, health scores and trend analysis tracked throughout the year.
• VIP Membership Program Recurring membership programme offering 10% discount across pathology tests, free sample collection for premium slots, up to 10 bookings per month at no convenience fee, and RedCash loyalty rewards for individual consumers.
• One Health Annual Subscription Plan Annual subscription for individual consumers including one initial full body checkup and 15 free tests up to ₹1,500 per order during the one-year validity, designed to drive recurring preventive testing.
• Redcliffe Labs Gift Cards Gift cards sold through the website and mobile app that can be redeemed against Redcliffe Labs' diagnostic services, valid for 12 months from issuance.

Quantifiable outcome

• Reports delivered within 14 hours of sample collection
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• Medicentre Sonography and Clinical Lab (Ajmer)coreStrategic or Co-development Partner · 16 June 2026Acquired leading diagnostic centre in Ajmer, Rajasthan operating as Redcliffe Medicentre Imaging & Labs. Facility equipped with 1.5 Tesla MRI and 128-slice CT scan, capable of over 1,200 MRI and 1,500 CT scans monthly.
• Celara DiagnosticscoreStrategic or Co-development Partner · 4 October 2024Acquired Bengaluru-based diagnostics chain with two high-end diagnostic centers and over 3,600 tests. Expands radiology and pathology services into South India. Brought on experts Dr. Radhesh S. and Dr. Rekha Radhesh.
• Medicentre Sonography & Clinical LabcoreStrategic or Co-development Partner · 31 March 2023Acquired largest independent diagnostic lab chain in Southern Rajasthan to position Redcliffe as largest integrated lab chain in Rajasthan. Deal involved mix of cash and equity.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Pathkind Labs: Indian diagnostics chain expanding aggressively in Tier 2/3 markets with home collection and B2B partnerships. Comparable growth-stage omnichannel model targeting similar underserved geographies.
• Dr. Lal PathLabs: Largest organized diagnostics chain in India, offering pathology and radiology across thousands of collection centres. Direct competitor in routine and preventive testing, with overlapping Tier 2/3 footprint and a stronger metro brand.
• Metropolis Healthcare: Pan-India diagnostic chain with strong presence in B2B hospital partnerships and B2C testing. Competes directly with Redcliffe on pathology menu, preventive health packages, and Tier 2/3 city expansion.
• Agilus Diagnostics (SRL Diagnostics): Large Indian diagnostics network offering pathology, radiology, and home sample collection. Closely comparable on omnichannel model and is actively pursuing inorganic expansion — directly overlapping Redcliffe's roll-up strategy.
• Thyrocare Technologies: Preventive-focused diagnostics chain owned by PharmEasy, known for low-cost routine and preventive packages. Competes on price-sensitive preventive health checkups — a core Redcliffe offering.
• Apollo Diagnostics: Diagnostics arm of Apollo Hospitals, offering pathology, imaging, and home collection across India. Comparable on integrated diagnostics + hospital referral model, with stronger hospital-anchored B2B demand.
• Healthians: Digital-first Indian diagnostics platform focused on home sample collection and preventive packages. Closely comparable GTM motion and Tier 2/3/4 customer base, competing head-on in the omnichannel home-collection segment.
• Tata 1mg (1mg Diagnostics): Digital health platform offering diagnostics, pharmacy, and teleconsultation. Competes with Redcliffe on D2C online booking, package-based preventive testing, and home sample collection.
• Suburban Diagnostics: Established Indian diagnostics provider with pathology, radiology, and home collection. Overlaps with Redcliffe in routine testing and home sample collection, particularly in western India.

Broad incumbents

• PharmEasy: Digital healthcare platform with diagnostics (via Thyrocare) and pharmacy operations. Adjacent competitor leveraging Thyrocare's lab network for D2C diagnostics packages similar to Redcliffe's preventive offerings.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/redcliffelab
• YouTubeyoutube.com/channel/UCb6BKQLMboW6Yt9b0l8TqFw
• Facebookfacebook.com/RedcliffeLabs
• LinkedInlinkedin.com/company/redcliffe-labs
• Instagraminstagram.com/redcliffelabs

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries3 records

Funding overview

Funding rounds7 records

Investors21 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Redcliffe Labs